Eli Lilly & Co.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$21,222
Revenue Growth (%)6.33%
Net Income (US$ Millions)$2,738
Earnings Per Share (US$)$2.58
EPS Growth Rate (%)14.16%
Profit Margin12.90%
Total Equity (US$ Millions)$14,008
Return on Equity (%)18.79%
Long Term Debt (US$ Millions)$8,368
Debt To Equity Ratio (%)0.60%
Total Assets (US$ Millions)$38,806
Current Assets (US$ Millions)$15,101
Current Liabilities (US$ Millions)$10,987
Cost of Goods Sold (US$ Millions)$5,655
Inventory Turnover1.61